# A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

> **NCT01479881** · PHASE1 · COMPLETED · sponsor: **Tibotec Pharmaceuticals, Ireland** · enrollment: 29 (actual)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** TMC435
- **DRUG:** cyclosporine
- **DRUG:** TMC435

## Key facts

- **NCT ID:** NCT01479881
- **Lead sponsor:** Tibotec Pharmaceuticals, Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479881, "A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01479881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*